# Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III

> **NCT05494801** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 203 (actual)

## Conditions studied

- Ebola Virus Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05494801
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-25
- **Primary completion:** 2023-03-25
- **Final completion:** 2023-03-25
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494801, "Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05494801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*